MTOR and colonic neoplasm: In the research of the antitumor effects of PP242, an inhibitor of mechanistic target of rapamycin (mTOR), in a colon cancer xenograft mouse model, Rashid et al. (2020) indicated that lysoPC (18:2) in the PP242-treated mice was significantly increased after mTOR inhibition.